HK1045332A1 - Compounds for therapy and diagnosis of lung cancer and methods for their use - Google Patents

Compounds for therapy and diagnosis of lung cancer and methods for their use

Info

Publication number
HK1045332A1
HK1045332A1 HK02106838.1A HK02106838A HK1045332A1 HK 1045332 A1 HK1045332 A1 HK 1045332A1 HK 02106838 A HK02106838 A HK 02106838A HK 1045332 A1 HK1045332 A1 HK 1045332A1
Authority
HK
Hong Kong
Prior art keywords
diagnosis
therapy
compounds
methods
lung cancer
Prior art date
Application number
HK02106838.1A
Other languages
Chinese (zh)
Inventor
G Reed Steven
J Lodes Michael
Mohamath Raodoh
Secrist Heather
Original Assignee
Corixa Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/370,838 external-priority patent/US6444425B1/en
Application filed by Corixa Corp filed Critical Corixa Corp
Publication of HK1045332A1 publication Critical patent/HK1045332A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2239/00—Indexing codes associated with cellular immunotherapy of group A61K39/46
    • A61K2239/46—Indexing codes associated with cellular immunotherapy of group A61K39/46 characterised by the cancer treated
    • A61K2239/55—Lung
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/46—Cellular immunotherapy
    • A61K39/461—Cellular immunotherapy characterised by the cell type used
    • A61K39/4611—T-cells, e.g. tumor infiltrating lymphocytes [TIL], lymphokine-activated killer cells [LAK] or regulatory T cells [Treg]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/46—Cellular immunotherapy
    • A61K39/464—Cellular immunotherapy characterised by the antigen targeted or presented
    • A61K39/4643—Vertebrate antigens
    • A61K39/4644—Cancer antigens
    • A61K39/464499—Undefined tumor antigens, e.g. tumor lysate or antigens targeted by cells isolated from tumor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Oncology (AREA)
  • Organic Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hospice & Palliative Care (AREA)
  • Zoology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
HK02106838.1A 1999-04-02 2002-09-19 Compounds for therapy and diagnosis of lung cancer and methods for their use HK1045332A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US28532399A 1999-04-02 1999-04-02
US09/370,838 US6444425B1 (en) 1999-04-02 1999-08-09 Compounds for therapy and diagnosis of lung cancer and methods for their use
US47623599A 1999-12-30 1999-12-30
US51880900A 2000-03-03 2000-03-03
PCT/US2000/008560 WO2000060077A2 (en) 1999-04-02 2000-03-30 Compounds for therapy and diagnosis of lung cancer and methods for their use

Publications (1)

Publication Number Publication Date
HK1045332A1 true HK1045332A1 (en) 2002-11-22

Family

ID=27501392

Family Applications (1)

Application Number Title Priority Date Filing Date
HK02106838.1A HK1045332A1 (en) 1999-04-02 2002-09-19 Compounds for therapy and diagnosis of lung cancer and methods for their use

Country Status (5)

Country Link
EP (1) EP1187915A2 (en)
JP (1) JP2002540790A (en)
AU (1) AU4185100A (en)
HK (1) HK1045332A1 (en)
WO (1) WO2000060077A2 (en)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6759508B2 (en) 2000-09-01 2004-07-06 Corixa Corporation Compositions and methods for the therapy and diagnosis of lung cancer
GB9924060D0 (en) * 1999-10-11 1999-12-15 Chiron Spa VIP54 protein
JP2004526401A (en) * 2000-03-29 2004-09-02 コリクサ コーポレイション Compositions and methods for treatment and diagnosis of lung cancer
WO2002018562A1 (en) * 2000-08-28 2002-03-07 Teijin Limited Airway-specific trypsin-like enzymes and method of using the same
AU2002302851A1 (en) 2001-06-21 2003-01-08 Isis Innovations Limited Atopy
AU2003256912A1 (en) * 2002-08-16 2004-03-03 Yeda Research And Development Co. Ltd. Tumor associated antigen, peptides thereof, and use of same as anti-tumor vaccines
WO2004016733A2 (en) * 2002-08-16 2004-02-26 Agensys, Inc. Nucleic acid and corresponding protein entitled 251p5g2 useful in treatment and detection of cancer
AU2007216892B2 (en) * 2002-08-16 2011-02-10 Agensys, Inc. Nucleic acids and corresponding proteins entitled 273P4B7 useful in treatment and detection of cancer
JP5648261B2 (en) * 2006-12-20 2015-01-07 東レ株式会社 Cancer detection method
CN102171570B (en) * 2008-08-05 2014-10-15 东丽株式会社 Cancer detection method
KR101638490B1 (en) 2008-08-05 2016-07-11 도레이 카부시키가이샤 Pharmaceutical composition for treatment and prevention of cancer
JP5906739B2 (en) 2010-02-04 2016-04-20 東レ株式会社 Pharmaceutical composition for treatment and / or prevention of cancer
CN109925511B (en) 2010-02-04 2024-03-19 东丽株式会社 Medicine for treating and/or preventing cancer
JP5742713B2 (en) 2010-02-04 2015-07-01 東レ株式会社 Pharmaceutical composition for treatment and / or prevention of cancer
CA2788545C (en) * 2010-02-04 2019-03-26 Toray Industries, Inc. Pharmaceutical composition for treating and/or preventing cancer
MX340014B (en) * 2010-02-04 2016-06-22 Toray Industries Pharmaceutical composition for treatment and/or prevention of cancer.
WO2011096519A1 (en) 2010-02-04 2011-08-11 東レ株式会社 Medicinal composition for treating and/or preventing cancer
PL2740798T3 (en) 2011-08-04 2017-07-31 Toray Industries, Inc. Cancer treatment and/or prevention drug composition
CA2844037C (en) 2011-08-04 2020-07-14 Toray Industries, Inc. Pharmaceutical composition for treatment and/or prevention of pancreatic cancer
DK2741085T3 (en) 2011-08-04 2017-06-19 Toray Industries Method for detecting pancreatic cancer
HUE039219T2 (en) 2011-08-04 2018-12-28 Toray Industries Pharmaceutical composition for treatment and/or prophylaxis of cancer
AU2012290957B2 (en) 2011-08-04 2017-04-20 Toray Industries, Inc. Pharmaceutical composition for treatment and/or prophylaxis of cancer
JP6065591B2 (en) 2011-08-04 2017-01-25 東レ株式会社 Pharmaceutical composition for treatment and / or prevention of cancer
DK2740793T3 (en) 2011-08-04 2018-01-22 Toray Industries PHARMACEUTICAL COMPOSITION FOR CANCER TREATMENT AND / OR PREVENTION
BR112014021103A2 (en) 2012-02-21 2019-10-15 Toray Industries, Inc ANTIBODY, PHARMACEUTICAL COMPOSITION, COMBINATION DRUG, DNA, METHOD OF TREATMENT AND USE OF ANTIBODY
US9573993B2 (en) 2012-02-21 2017-02-21 Toray Industries, Inc. Pharmaceutical composition for treatment of cancer comprising an anti-CAPRIN-1 peptide antibody
JP6187255B2 (en) 2012-02-21 2017-08-30 東レ株式会社 Pharmaceutical composition for treatment and / or prevention of cancer
PT2818481T (en) 2012-02-21 2019-10-25 Toray Industries Pharmaceutical composition for treatment and/or prevention of cancer
KR102052400B1 (en) 2012-03-30 2019-12-06 도레이 카부시키가이샤 Pharmaceutical composition for treatment and/or prevention of gall bladder cancer
CA2869120C (en) 2012-03-30 2023-05-23 Toray Industries, Inc. Pharmaceutical composition for treatment and/or prevention of liver cancer
TR201902972T4 (en) 2012-07-19 2019-03-21 Toray Industries Method for detecting cancer.
DK2876447T3 (en) 2012-07-19 2020-02-24 Toray Industries Method for detecting cancer
PL3031826T3 (en) 2013-08-09 2019-03-29 Toray Industries, Inc. Pharmaceutical composition for treatment and/or prevention of cancer

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5589579A (en) * 1994-07-19 1996-12-31 Cytoclonal Pharmaceutics, Inc. Gene sequence and probe for a marker of non-small cell lung carinoma
ID27813A (en) * 1998-01-28 2001-04-26 Corixa Corp COMPOUNDS FOR THERAPY AND DIAGNOSIS OF LUNG CANCER AND METHODS FOR USE

Also Published As

Publication number Publication date
JP2002540790A (en) 2002-12-03
AU4185100A (en) 2000-10-23
WO2000060077A2 (en) 2000-10-12
WO2000060077A3 (en) 2002-01-17
EP1187915A2 (en) 2002-03-20

Similar Documents

Publication Publication Date Title
HK1045332A1 (en) Compounds for therapy and diagnosis of lung cancer and methods for their use
HUP0200760A2 (en) Compounds and methods for therapy and diagnosis of lung cancer
HUP0201757A3 (en) Compositoins and methods for the therapy and diagnosis of lung cancer
ZA99693B (en) Compounds for therapy and diagnosis of lung cancer and methods for their use.
PL366626A1 (en) Compositions and methods for the therapy and diagnosis of lung cancer
AU1807401A (en) Compositions and methods for therapy and diagnosis of breast cancer
GB9903841D0 (en) Diagnosis and treatment of cancer
HUP0200763A2 (en) Compositions for the treatment and diagnosis of breast cancer and methods for their use
HUP0203968A3 (en) Compositions and methods for the therapy and diagnosis of prostate cancer
PL346359A1 (en) Compositions and methods for therapy and diagnosis of prostate cancer
AU2002218770A1 (en) Compositions and methods for the therapy and diagnosis of lung cancer
EP1516049A4 (en) Compositions and methods for the therapy and diagnosis of lung cancer
PL365244A1 (en) Compositions and methods for the therapy and diagnosis of breast cancer
AU3391200A (en) Compositions and methods for breast cancer therapy and diagnosis
EP1446013A4 (en) Compositions and methods for the therapy and diagnosis of lung cancer
AU2002246519A8 (en) Compositions and methods for the therapy and diagnosis of colon cancer
PL350890A1 (en) Compounds for immunotherapy and diagnosis of breast cancer and methods for their use
AU2001259062A1 (en) Compositions and methods for the therapy and diagnosis of lung cancer
AU2001243349A1 (en) Methods for the diagnosis and treatment of breast cancer
EP1420814A4 (en) Compositions and methods for the therapy and diagnosis of breast cancer
AU5638400A (en) Compositions and methods for the therapy and diagnosis of breast cancer
PL366066A1 (en) Compositions and methods for the therapy and diagnosis of breast cancer
AU2001273149A1 (en) Compositions and methods for the therapy and diagnosis of lung cancer
AU2003230849A8 (en) Compositions and methods for the therapy and diagnosis of lung cancer
AU2001273127A1 (en) Compositions and methods for the therapy and diagnosis of lung cancer